This "Personal View" paper, published by a multi-institutional team led by researchers at Fudan University, provides a comprehensive analysis of the shifting landscape of Avian Influenza Virus (AIV) over the last decade (2013–2023). It synthesizes epidemiological data, genomic advancements, and control strategies to warn of an increasing "spillover" risk to humans.
TL;DR
Over the past decade, the diversity of avian influenza subtypes infecting humans has doubled, characterized by a 37% case fatality rate and a dramatic geographic expansion into Europe and the Americas. The paper argues that while advanced genomic surveillance (like nanopore sequencing) has improved our tracking of these "jumps," a globally coordinated "One Health" approach—integrating biosecurity, targeted vaccination, and environmental monitoring—is the only way to prevent the next pandemic.
What Problem Does This Paper Address?
The world is currently facing the "worst-ever" period of avian influenza epizootics (animal epidemics). While AIVs primarily circulate in birds, they frequently "spill over" into mammals and humans. The authors address three critical gaps:
- Changing Epidemiology: The transition from a few dominant strains (like H5N1) to a complex "alphabet soup" of emerging subtypes (H7N9, H5N6, H3N8, etc.).
- The "Clinical Iceberg": The likelihood that the true disease burden is underestimated due to insufficient diagnostic capacity at the human-animal interface.
- Control Fragmentation: The need for a unified strategy that moves beyond reactive culling toward proactive genomic surveillance and "One Health" integration.
Methods
As a "Personal View" or review-style paper, the authors did not conduct new laboratory experiments but performed a rigorous meta-analysis and synthesis:
- Data Collation: They collected comprehensive surveillance and mortality data from January 1, 2013, to June 6, 2023, using sources like the WHO Weekly Epidemiological Record and China’s National Health Commission.
- Genomic Analysis Review: They evaluated the role of state-of-the-art computational tools—such as Bayesian phylogenetic analysis (using software like BEAST and RAxML) and Next-Generation Sequencing (NGS)—in tracing viral introduction and transmission chains.
- Policy Evaluation: They reviewed the effectiveness of specific interventions, such as China’s "1110" biosecurity strategy for live poultry markets.
Datasets
The study utilized several publicly available official databases:
- WHO: Weekly Epidemiological Record (WER) and Monthly Risk Assessment Summaries.
- National Health Commission of China: Reports for confirming human cases in the mainland.
- Hong Kong Centre for Health Protection: Weekly reports.
- Genomic Repositories: References to sequences from GenBank and GISAID to estimate mammal infections.
Key Insights and Ideas
- The Subtype Explosion: In the decade prior to 2013, only six AIV subtypes were reported in humans. In the last decade, that number doubled to 12 subtypes (8 emerging, 4 re-emerging).
- The "Male Disparity": Interestingly, the number of male human cases was nearly double that of females (1.8:1). While the biological reason remains under investigation, it likely reflects occupational exposure patterns in poultry handling.
- Molecular "Red Flags": The paper highlights specific mutations that increase human risk. For instance, the HA 228S mutation in H3N8 and HA G228S in H10N3 increase the virus's affinity for human-type receptors (α2-6 sialic acid).
- The "1110" Strategy: China’s success in reducing H7N9 cases is attributed to a specific biosecurity protocol: cleaning 1 day/week, disinfecting 1 day/week, shutting down 1 day/month, and butchering all unsold birds 0 (every) day.
- Mammalian Expansion: The recent "panzootic" of H5N1 has naturally infected over 48 species of mammals, including a concerning rise in companion animals like cats, which could serve as intermediate hosts closer to humans.
Key Results
- Human Toll: 2,050 laboratory-confirmed human cases were identified between 2013 and 2023.
- High Mortality: The overall "crude" case fatality rate (CFR) was a staggering 37% worldwide.
- Dominant Strains: H7N9 accounted for the majority of cases (1,568), followed by H5N1 (266) and H9N2 (106).
- Seasonality: AIV is a "winter" threat, with 64% of cases reported globally between January and March.
- Vaccination Success: After China introduced the H5/H7 bivalent inactivated vaccine for poultry in 2017, the H7N9 isolation rate in poultry dropped by 93.3%, effectively halting the human infection wave.
Limitations and Future Work
- Surveillance Gaps: The authors acknowledge that many cases go undetected in regions with poor infrastructure, leading to a "silent transmission" risk.
- Neglected Hosts: There is an urgent need to include "neglected" mammalian hosts—specifically stray cats and dogs—in routine AIV surveillance, as they live in close proximity to both poultry and humans.
- Data Sharing: A major barrier remains the lack of real-time genomic data sharing across borders, which is essential for early warning systems.
- Vaccine Development: While poultry vaccines exist, the authors call for the development of "universal" mRNA influenza vaccines for humans that could cover all 20 known IAV subtypes.
Summary updated